Digital Health Ventures - Liquid Biopsy

As of October 2024, 127 Digital Health ventures are using Liquid Biopsy technologies. The volume of these ventures has grown at a compound annual growth rate (CAGR) of 4.1% over the last five years.
In terms of business maturity, these ventures have garnered an average Maturity Score of 55.0, a 360° Venture Maturity assessment that aggregates four distinct and independent Alpha Indices: Momentum Index, Market Index, Money Index and Innovation Index.

From a funding perspective, these Digital Health companies have successfully raised $6.29B in venture capital investments, channeled through 353 distinct funding rounds. In the past 12 months, total venture capital funding closed at $850.04M.